With respect to hepatocellular carcinoma (HCC), Eunice et al. demonstrated that CAFs regulate liver tumor-initiating cells and found that the presence of α-SMA-positive CAF cells correlated with poor clinical outcome, corroborating earlier studies as well [56,90]. The gene discussed is ACTA1; the disease is hepatocellular carcinoma.